Medico Intercontinental Share Price

  • 47.50-0.40 (-0.83%)
  • Volume: 7,835
BSE
  • Closed
  • Last Updated On: 29 Aug, 2024, 03:48 PM IST
Loading...

Medico Intercontinental...

  • 47.50-0.40 (-0.83%)
  • Volume: 7,835
Advertisment

Medico Intercontinental share price insights

View All
  • Sales de-grew by 6.49%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 20.35% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 5.49% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

  • Medico Intercontinental Ltd. share price moved down by -0.83% from its previous close of Rs 47.90. Medico Intercontinental Ltd. stock last traded price is 47.50

    Share PriceValue
    Today/Current/Last-47.50
    Previous Day-47.90

InsightsMedico Intercontinental

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    11.85
    EPS - TTM
    (₹)
    4.01
    MCap
    (₹ Cr.)
    47.50
    Sectoral MCap Rank
    129
    PB Ratio
    (x)
    1.06
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month0.45
    3 Months0.59
    6 Months0.76
    1 Year0.31
    3 Years-

    0.45
    VWAP
    (₹)
    46.60
    52W H/L
    (₹)
    122.00 / 39.00

    Medico Intercontinental Share Price Returns

    1 Day-0.83%
    1 Week0.79%
    1 Month4.51%
    3 Months3.64%
    1 Year-39.1%
    3 Years19.35%
    5 Years-46.99%

    ET Stock ScreenersTop Score Companies

    Check whether Medico Intercontinental belongs to analysts' top-rated companies list?

    View Stock Screeners

    Medico Intercontinental Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Medico Intercontinental Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Medico Intercontinental Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Topline Contraction

        Sales de-grew by 6.49%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 5.49% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income18.3615.8414.3417.2124.36
      Total Income Growth (%)15.8710.47-16.63-29.38-16.77
      Total Expenses16.6914.2412.8415.8822.87
      Total Expenses Growth (%)17.2210.90-19.12-30.57-17.51
      EBIT1.671.601.501.331.50
      EBIT Growth (%)3.896.7513.08-11.22-3.49
      Profit after Tax (PAT)1.081.041.020.871.02
      PAT Growth (%)4.541.8216.90-14.860.77
      EBIT Margin (%)9.0810.1210.487.726.14
      Net Profit Margin (%)5.906.547.105.064.20
      Basic EPS (₹)1.081.041.020.871.02
      Quarterly | AnnualJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
      Total Income11.6210.047.4110.0516.96
      Total Income Growth (%)15.7535.61-26.30-40.74-25.40
      Total Expenses10.849.296.699.3816.25
      Total Expenses Growth (%)16.6838.96-28.67-42.29-25.59
      EBIT0.780.750.720.670.71
      EBIT Growth (%)4.104.316.74-5.31-20.68
      Profit after Tax (PAT)0.500.470.480.480.48
      PAT Growth (%)6.74-1.98-0.25-0.77-17.82
      EBIT Margin (%)6.707.459.696.694.19
      Net Profit Margin (%)4.284.646.424.742.83
      Basic EPS (₹)0.500.470.480.480.48
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue71.7676.7474.5769.9282.01
      Total Revenue Growth (%)-6.492.916.65-14.75695.56
      Total Expenses66.3271.7970.3466.3978.81
      Total Expenses Growth (%)-7.632.075.95-15.77747.17
      Profit after Tax (PAT)3.953.613.102.582.36
      PAT Growth (%)9.3916.4020.329.31220.21
      Operating Profit Margin (%)8.317.296.875.265.24
      Net Profit Margin (%)5.534.734.173.692.87
      Basic EPS (₹)3.955.619.547.937.25
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue44.4549.2339.4341.1946.96
      Total Revenue Growth (%)-9.6924.85-4.27-12.29355.50
      Total Expenses41.8346.8537.6039.5345.42
      Total Expenses Growth (%)-10.7124.60-4.88-12.98389.45
      Profit after Tax (PAT)1.901.701.311.191.12
      PAT Growth (%)11.2729.959.796.8547.33
      Operating Profit Margin (%)6.465.615.985.944.66
      Net Profit Margin (%)4.303.483.342.912.38
      Basic EPS (₹)1.902.654.043.683.44

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets56.0458.8831.9430.6536.04
      Total Assets Growth (%)-4.8284.344.23-14.97294.88
      Total Liabilities11.0117.6919.3121.1129.68
      Total Liabilities Growth (%)-37.78-8.34-8.55-28.88479.30
      Total Equity45.0341.1912.649.546.36
      Total Equity Growth (%)9.34225.9632.5149.9258.87
      Current Ratio (x)4.283.242.171.932.05
      Total Debt to Equity (x)0.110.110.680.942.15
      Contingent Liabilities0.004.514.51--
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets39.4444.3817.7216.4219.17
      Total Assets Growth (%)-11.13150.457.92-14.35110.20
      Total Liabilities3.3510.0810.0610.0814.03
      Total Liabilities Growth (%)-66.770.20-0.20-28.15175.64
      Total Equity36.1034.307.656.345.15
      Total Equity Growth (%)5.25348.3720.6623.1127.79
      Current Ratio (x)8.874.172.932.232.81
      Total Debt to Equity (x)0.030.070.810.761.66
      Contingent Liabilities0.004.514.51--

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 8.54 cr for investing activities which is an YoY increase of 58.57%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities5.58-10.103.855.82-13.82
      Net Cash used in Investing Activities-8.54-5.38-1.30-0.94-3.70
      Net Cash flow from Financing Activities-0.4620.41-1.20-5.1413.42
      Net Cash Flow-3.424.921.35-0.26-4.11
      Closing Cash & Cash Equivalent3.376.791.870.51-
      Closing Cash & Cash Equivalent Growth (%)-50.41263.81262.31-56.410.00
      Total Debt/ CFO (x)0.87-0.472.241.54-0.99
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities5.73-11.951.105.44-6.55
      Net Cash used in Investing Activities-6.65-5.02-0.80-0.94-3.68
      Net Cash flow from Financing Activities-1.6320.630.87-4.519.22
      Net Cash Flow-2.543.661.17-0.02-1.01
      Closing Cash & Cash Equivalent2.414.951.290.120.14
      Closing Cash & Cash Equivalent Growth (%)-51.40285.001,010.21-16.02-88.01
      Total Debt/ CFO (x)0.17-0.195.660.89-1.31

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)8.768.7624.5327.0137.05
      Return on Capital Employed (%)12.6012.7827.0122.7822.09
      Return on Assets (%)7.046.129.708.406.53
      Interest Coverage Ratio (x)12.619.326.0736.024.02
      Asset Turnover Ratio (x)1.241.281.62227.57227.41
      Price to Earnings (x)10.1022.996.103.242.14
      Price to Book (x)0.882.011.500.870.79
      EV/EBITDA (x)6.6514.034.833.394.07
      EBITDA Margin (%)8.717.567.147.095.37
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)5.254.9717.1418.8421.73
      Return on Capital Employed (%)7.707.5617.3821.9216.03
      Return on Assets (%)4.803.847.407.275.83
      Interest Coverage Ratio (x)13.577.714.713.213.38
      Asset Turnover Ratio (x)1.051.572.30249.81244.80
      Price to Earnings (x)21.0148.7814.416.984.52
      Price to Book (x)1.102.422.471.310.98
      EV/EBITDA (x)12.6928.339.715.216.08
      EBITDA Margin (%)6.875.796.256.094.72

    Financial InsightsMedico Intercontinental

    • Income (P&L)
    • Cash Flow
      • Topline Contraction

        Sales de-grew by 6.49%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 5.49% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 8.54 cr for investing activities which is an YoY increase of 58.57%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Medico Intercontinental Peer Comparison

    • Medico Intercontinental Stock Performance

    • Ratio Performance

    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 20.35% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)
      • There’s no suggested peer for this stock.
      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 20.35% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

      Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Medico Intercontinental11.851.058.7612.607.040.868.315.533.954.280.110.87
      Add More stocks of your interest to compare.
      Annual Ratios (%)

      Choose from Peers

        Choose from Stocks

        Peers InsightsMedico Intercontinental

        • Stock Returns vs Nifty Smallcap 100

          Stock gave a 3 year return of 20.35% as compared to Nifty Smallcap 100 which gave a return of 92.43%. (as of last trading session)

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Medico Intercontinental Shareholding Pattern

        • QOQ Change

        • Total Shareholdings

        • Loading...
          Showing Medico Intercontinental Shareholding as on 30 Jun 2024
          Category30 Jun 202431 Mar 202431 Dec 202330 Sep 2023
          Promoters55.0855.0855.0854.78
          Pledge0.000.000.000.00
          FII0.000.000.000.00
          DII0.000.000.000.00
          Mutual Funds0.000.000.000.00
          Others44.9244.9244.9245.22
        • Showing Shareholding as on 30 Jun 2024
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters55,07,62555.08 %0.00
          Pledge00.00 %0.00
          Others44,92,37544.92 %0.00

        MF Ownership

        MF Ownership details are not available.

        Corporate Actions

        • Medico Intercontinental Board Meeting/AGM

        • Medico Intercontinental Dividends

        • Others
        • Meeting DateAnnounced onPurposeDetails
          Aug 13, 2024Aug 06, 2024Board MeetingQuarterly Results
          May 25, 2024May 21, 2024Board MeetingAudited Results
          May 10, 2024May 06, 2024Board MeetingOthers
          May 07, 2024May 06, 2024Board MeetingOthers
          Feb 14, 2024Feb 06, 2024Board MeetingQuarterly Results
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final1%0.1Jun 23, 2023May 29, 2023
        • No other corporate actions details are available.

        About Medico Intercontinental

        Medico Intercontinental Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 47.90 Crore) operating in Miscellaneous sector. Medico Intercontinental Ltd. key Products/Revenue Segments include Pharmaceutical Products for the year ending 31-Mar-2023. Show More

        • Executives

        • Auditors

        • TS

          Tanvi Shah

          Chairman & Non-Exe.Director
          SS

          Samir Shah

          Managing Director
          DB

          Dilipkumar Bhogilal Shah

          Chief Executive Officer
          SV

          Swati Vikramkumar Shah

          Non Executive Director
          Show More
        • V Goswami & Co.

        FAQs about Medico Intercontinental share

        • 1. What is Medico Intercontinental share price and what are the returns for Medico Intercontinental share?
          Medico Intercontinental share price was Rs 47.50 as on 29 Aug, 2024, 03:48 PM IST. Medico Intercontinental share price was down by 0.83% based on previous share price of Rs. 48.44.
        • 2. What is 52 week high/low of Medico Intercontinental share price?
          Medico Intercontinental share price saw a 52 week high of Rs 122.00 and 52 week low of Rs 39.00.
        • 3. What is the market cap of Medico Intercontinental?
          Within the Miscellaneous sector, Medico Intercontinental stock has a market cap rank of 129. Medico Intercontinental has a market cap of Rs 47.50 Cr.
        • 4. Who is the CEO of Medico Intercontinental?
          Dilipkumar Bhogilal Shah is the Chief Executive Officer of Medico Intercontinental
        • 5. What are the returns for Medico Intercontinental share?
          Return Performance of Medico Intercontinental Shares:
          • 1 Week: Medico Intercontinental share price moved up by 0.79%
          • 3 Month: Medico Intercontinental share price moved up by 3.64%
          • 6 Month: Medico Intercontinental share price moved down by 24.12%
        • 6. What is the PE & PB ratio of Medico Intercontinental?
          The PE ratio of Medico Intercontinental stands at 11.95, while the PB ratio is 1.06.
        • 7. Who owns Medico Intercontinental?
          Following are the key changes to Medico Intercontinental shareholding:
          • Promoter holding has gone up from 54.78 (30 Sep 2023) to 55.08 (30 Jun 2024)
          • Other investor holding have gone down from 45.22 (30 Sep 2023) to 44.92 (30 Jun 2024)
        • 8. Is Medico Intercontinental giving dividend?
          An equity Final dividend of Rs 0.1 per share was declared by Medico Intercontinental Ltd. on 29 May 2023. So, company has declared a dividend of 1% on face value of Rs 10 per share. The ex dividend date was 23 Jun 2023.
        • 9. How can I quickly analyze Medico Intercontinental stock?
          Medico Intercontinental share can be quickly analyzed on following metrics:
          • Stock's PE is 11.85
          • Price to Book Ratio of 1.06
        • 10. What are the Medico Intercontinental quarterly results?
          On Consoldiated basis, Medico Intercontinental reported a total income and profit of Rs 18.36 Cr and Rs 1.08 respectively for quarter ending 2024-06-30. Total Income and profit for the year ending 2024-03-31 was Rs 71.76 Cr and Rs 3.95 Cr.
        • 11. Who is the chairman of Medico Intercontinental?
          Tanvi Shah is the Chairman & Non-Exe.Director of Medico Intercontinental
        • 12. What is the CAGR of Medico Intercontinental?
          The CAGR of Medico Intercontinental is 0.57.

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times